Overall survival data from EMBARK trial support enzalutamide plus leuprolide as standard of care. Medscape Medical News Source link : https://www.medscape.com/viewarticle/enzalutamide-extends-survival-high-risk-prostate-cancer-2025a1000sk5?src=rss Author : Publish date : 2025-10-21 14:48:00 Copyright for...

(MedPage Today) -- ORLANDO -- The investigational interleukin (IL)-6 inhibitor vamikibart led to visual improvements in uveitic macular edema in two identical phase III trials, with one exception. In the...

(MedPage Today) -- Focal treatment-resistant epilepsy may improve over time, longitudinal data from the Human Epilepsy Project 2 suggested. Among people with focal treatment-resistant epilepsy who were followed for up...

New ‘concerning’ data find that most US endoscopists aren’t following current polypectomy guidelines for polyps < 1 cm, potentially exposing patients to unnecessary risks. Medscape Medical News Source link :...

Elena Prendergast’s path isn’t for everyone but is proof we can all re-invent ourselves. Medscape Medical News Source link : https://www.medscape.com/viewarticle/you-can-do-this-becoming-nurse-practitioner-49-2025a1000sji?src=rss Author : Publish date : 2025-10-21 14:01:00 Copyright for...

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant improvements in progression-free and overall survival were seen. Medscape Medical News Source link : https://www.medscape.com/viewarticle/pembro-plus-weekly-paclitaxel-boosts-ovarian-cancer-survival-2025a1000sjk?src=rss...

Screening done before age 2 is not sensitive enough, and screening at age 3 or later can miss the ideal time for intervention. Medscape Medical News Source link : https://www.medscape.com/viewarticle/age-2-5-emerges-earliest-effective-screening-age-2025a1000sjl?src=rss...

(MedPage Today) -- Note that some links may require registration or subscription. Immigration and Customs Enforcement (ICE) is hiring more than 40 doctors, nurses, psychiatrists, pharmacists, and health administrators after...

Children paid a "huge price" to protect others during the Covid pandemic, Boris Johnson has told the inquiry looking at the impact on young people.The former prime minister repeated an...

Patients who live with CF are faced with a variety of health and lifestyle challenges. When might be the best time to talk about fertility and family planning? Medscape Medical...

BBC100-year-old May O'Shea survived the blitz during the Second World War"I never thought I'd make it to this age," says 100-year-old May O'Shea. "I thought I would have died by...

Giving US veterans the latest COVID‑19 vaccine alongside the influenza vaccine is linked to fewer ED visits, hospitalizations, and deaths vs giving the influenza vaccine alone. Medscape Medical News Source...

Share on PinterestMany popular protein powders and shakes may contain lead, according to Consumer Reports. Anna Blazhuk/Getty ImagesA new Consumer Reports investigation found that many popular protein powders and shakes...

Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with pulmonary arterial hypertension at an intermediate or high risk for death....

ContributedIris Scott, 73, was a patient at the Crystal Centre in Chelmsford A woman who took her own life while on a mental health ward had been threatened and bullied...

PA MediaDenise Bacon experienced instant improvement in her finger movementsA woman with Parkinson's disease who played a clarinet while undergoing brain stimulation said she was "delighted" with how it went.Denise...

Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ejection fraction. Medscape Medical News Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-best-arnis-frail-older-adults-hfpef-2025a1000shi?src=rss Author : Publish date...

(MedPage Today) -- The number of physicians serving Medicare patients grew from 2013 to 2023, but program exit rates in rural and underserved areas increased, according to an analysis of...

(MedPage Today) -- BERLIN -- Non-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be alive 3 years later if they got a COVID-19 vaccine...

(MedPage Today) -- CHICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA Adverse Event Reporting System (FAERS) showed. In...